1-5 of 5
Authors: John G. Fort
Journal Article
OR-25: Rofecoxib, but not celecoxib or naproxen, increases mean 24-hour systolic blood pressure: Results of a randomized double blind controlled trial in treated hypertensive patients with osteoarthritis (OA) and type 2 diabetes mellitus
American Journal of Hypertension, Volume 16, Issue S1, May 2003, Page 11A, https://doi.org/10.1016/S0895-7061(03)00109-2
Published: 01 May 2003
Journal Article
P-245: Differential effects of COX-2 inhibitors on systolic blood pressure in hypertensive patients treated with ACE inhibitors and beta-blockers versus calcium antagonists Get access
American Journal of Hypertension, Volume 15, Issue S3, April 2002, Page 119A, https://doi.org/10.1016/S0895-7061(02)02596-7
Published: 01 April 2002
Journal Article
P-244: The effects of COX-2 specific inhibitors on edema and systolic blood pressure in elderly patients with osteoarthritis and treated hypertension: a pooled analysis on 1,902 patients Get access
American Journal of Hypertension, Volume 15, Issue S3, April 2002, Page 118A, https://doi.org/10.1016/S0895-7061(02)02595-5
Published: 01 April 2002
Journal Article
P-247: The effect of COX-2 specific inhibitors on blood pressure control in patients with osteoarthritis and hypertension Get access
American Journal of Hypertension, Volume 15, Issue S3, April 2002, Pages 119A–120A, https://doi.org/10.1016/S0895-7061(02)02598-0
Published: 01 April 2002
Journal Article
P-447: Blood pressure control and edema rates in older patients with systolic hypertension and osteoarthritis following treatment with COX-2 specific inhibitors Get access
American Journal of Hypertension, Volume 14, Issue S1, April 2001, Page 181A, https://doi.org/10.1016/S0895-7061(01)01619-3
Published: 01 April 2001
